SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New Hampshire

Bank of New Hampshire trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.2% in the first quarter, Holdings Channel.com reports. The institutional investor owned 690 shares of the exchange traded fund’s stock after selling 233 shares during the quarter. Bank of New Hampshire’s holdings in SPDR S&P Biotech ETF were worth $65,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of XBI. Kestra Advisory Services LLC raised its position in shares of SPDR S&P Biotech ETF by 5.7% in the third quarter. Kestra Advisory Services LLC now owns 23,358 shares of the exchange traded fund’s stock valued at $1,706,000 after buying an additional 1,265 shares during the last quarter. Envestnet Asset Management Inc. increased its position in SPDR S&P Biotech ETF by 5.8% during the third quarter. Envestnet Asset Management Inc. now owns 126,001 shares of the exchange traded fund’s stock worth $9,201,000 after purchasing an additional 6,884 shares during the last quarter. Mariner LLC increased its position in SPDR S&P Biotech ETF by 6.3% during the third quarter. Mariner LLC now owns 33,396 shares of the exchange traded fund’s stock worth $2,439,000 after purchasing an additional 1,970 shares during the last quarter. EPG Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock worth $34,000 after purchasing an additional 278 shares during the last quarter. Finally, Valley National Advisers Inc. increased its position in SPDR S&P Biotech ETF by 66.8% during the third quarter. Valley National Advisers Inc. now owns 4,319 shares of the exchange traded fund’s stock worth $315,000 after purchasing an additional 1,729 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.8 %

SPDR S&P Biotech ETF stock opened at $92.38 on Friday. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52. The stock has a market cap of $7.04 billion, a P/E ratio of 11.47 and a beta of 1.11. The company has a 50-day moving average price of $89.12 and a 200 day moving average price of $90.26.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.